Quantamental Technologies’s Amneal Pharmaceuticals AMRX Stock Holding History

Quantamental Technologies’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,810	Closed	-$52K	–	362
2021 Q4	$52K	Sell	10,810 -1,618	-13%	-$8.07K	0.03%	369
2021 Q3	$66K	Buy	12,428 +221	+2%	+$1.11K	0.04%	278
2021 Q2	$63K	Buy	+12,207	New	+$69.4K	0.06%	234
2019 Q4	–	Sell	-3,323	Closed	-$10K	–	462
2019 Q3	$10K	Sell	3,323 -2,800	-46%	-$9.77K	﹤0.01%	1313
2019 Q2	$44K	Sell	6,123 -577	-9%	-$5.9K	0.02%	930
2019 Q1	$95K	Buy	6,700 +1,700	+34%	+$22.5K	0.04%	620
2018 Q4	$68K	Buy	+5,000	New	+$90.1K	0.04%	685

Other funds holding AMRX

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Quantamental Technologies's AMRX Position: Q1 2022 in Review

Quantamental Technologies sold out of Amneal Pharmaceuticals (AMRX) in Q1 2022, closing a stake of 10,810 shares — an estimated $52K sold.

Quantamental Technologies first reported a position in AMRX in Q4 2018 and held it in 7 quarters. The position peaked at $95K in Q1 2019. 168 funds tracked by Wall St. Rank hold AMRX as of Q1 2022.

Quantamental Technologies reported no remaining Amneal Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Quantamental Technologies sold 10,810 Amneal Pharmaceuticals shares in Q1 2022, an estimated $52K.
Quantamental Technologies first reported a position in Amneal Pharmaceuticals in Q4 2018 and held it in 7 quarters.
Quantamental Technologies's Amneal Pharmaceuticals position peaked at $95K in Q1 2019.
168 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q1 2022.

Based on Quantamental Technologies's 13F filing for Q1 2022, filed 16 May 2022.